Shares of Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) were up 12.5% on Wednesday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 241,165 shares traded hands during mid-day trading, an increase of 285% from the average session volume of 62,690 shares. The stock had previously closed at C$0.12.
Nanalysis Scientific Price Performance
The firm has a market capitalization of C$18.69 million, a PE ratio of -2.70 and a beta of -0.52. The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.10. The firm has a 50-day simple moving average of C$0.14 and a 200-day simple moving average of C$0.15.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.
Read More
- Five stocks we like better than Nanalysis Scientific
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
- EVs Are Big Winners of the Iran War—Just Not American Ones
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
